Comparative Efficacy and Safety of Doravirine/Islatravir versus Contemporary ART Regimens in Virologically Suppressed People Living with HIV-1 at 48 Weeks: A Systematic Review and Network Meta-Analysis

Conference Reports for NATAP

HIV Glasgow 2026
8-11 November


Comparative Efficacy and Safety of Doravirine/Islatravir versus Contemporary ART Regimens in Virologically Suppressed People Living with HIV-1 at 48 Weeks: A Systematic Review and Network Meta-Analysis

	Glasgow 2026 Nov 8-11